[
  {
    "title": "Returns At Abbott Laboratories (NYSE:ABT) Are On The Way Up",
    "published": 1742562016
  },
  {
    "title": "Abbott (ABT) Gains But Lags Market: What You Should Know",
    "published": 1742421614
  },
  {
    "title": "RFK Jr.\u2019s Next\u00a0Targets Are Companies Making Baby Formula",
    "published": 1742345428
  },
  {
    "title": "Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?",
    "published": 1742304610
  },
  {
    "title": "Reckitt\u2019s Mead Johnson, Abbott to face new trial in US infant-formula case",
    "published": 1742238521
  },
  {
    "title": "Abbott Laboratories Gains 12.7% in a Year: What's Driving the Stock?",
    "published": 1742220900
  },
  {
    "title": "Citi sees overturned verdict in state case as incrementally negative for Abbott",
    "published": 1742048110
  },
  {
    "title": "Baby Formula Makers Abbott and Reckitt See Stocks Slide as Judge Allows Retrial",
    "published": 1741987905
  },
  {
    "title": "S&P 500 Gains and Losses Today: Index Bounces Off Lows as Government Shutdown Concerns Ease",
    "published": 1741984393
  },
  {
    "title": "AstraZeneca Stock Scores RS Rating Upgrade",
    "published": 1741982520
  },
  {
    "title": "US Equities Markets End Higher Friday Amid Expectations US Government Can Avoid Shutdown",
    "published": 1741982490
  },
  {
    "title": "Top Midday Decliners",
    "published": 1741975726
  },
  {
    "title": "Abbott (ABT) Stock Moves -0.3%: What You Should Know",
    "published": 1741902616
  }
]